The phrase "ability to detect at" is not correct as it is incomplete and lacks context.
It can be used when discussing the capacity to identify something at a specific location or time, but it needs additional information to be meaningful.
Example: "The ability to detect at various frequencies is crucial for this technology."
Alternatives: "capacity to identify at" or "skill to recognize at".
Through this approach, as low as 10 aM synthetic hly gene targets and about 0.0002 ng/μl of genomic DNA from L. monocytogenes can be detected, the ability to detect at such ultratrace levels could be attributed to the powerful amplification of HRCA and the high sensitivity of current magnetic bead based ECL detection platform.
Its power resides in the ability to detect, at every cycle of the PCR, the amount of PCR product (amplicon) using fluorescence.
Required number of person-years and GP practices (recruiting 100 patients from each practice) by country, based on the relative populations of the 4 UK countries * Incidence of GP presentation in original IID study Note: Based on the ability to detect at least a 20% reduction in incidence with 90% power and 95% precision.
Our preceding studies nonetheless showed that the addition of LTRA to ICS in the numerator yielded close conclusions regarding the ability to detect at-risk patients [ 4, 13].
These include the ability to detect xenobiotics at concentrations at the cellular and molecular level, to detect earlier biologic changes presumptive of disease or disease risk, and to identify a detailed continuum of events between an exposure and resultant disease.
However, our ability to detect patients at increased risk was limited to conditions detectable by medical and pharmacy claims.
At follow-up, 43% of those with impaired awareness at enrollment reported restoration of the ability to detect hypoglycemia at a blood glucose >3 mmol/L.
Because typical Raman scattering cross-sections are much smaller than those of fluorescent processes, however, Raman spectroscopy is limited in its ability to detect molecules at low concentrations.
Nanotechnology also offers the ability to detect diseases at much earlier stages, such as finding hidden or overt metastatic colonies often seen in patients diagnosed with breast, lung, colon, prostate, and ovarian cancer.
We consider how we can ensure licensing is effective, particularly when considering the rapid changes in our understanding of the impacts of discharges, the technical advances in our ability to detect chemicals at low concentrations and the progress in wastewater treatment technology.
The rapid advancement of omic techniques in recent years has made it possible to search for biomarkers for specific human diseases in a systematic and comprehensive manner, which is substantially improving our ability to detect diseases at early stages.
